Skip to content

Iron Triangle Partners LP: CAH position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Iron Triangle Partners LP on CAH, newest first. How the timeline and the estimate are built.

Iron Triangle Partners LP held 0 CAH shares at 2025-12-31 per its 13F-HR filed 2026-02-17.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -138,011 shares

    13F-HR 0001172661-26-000928 filed by Iron Triangle Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 138,011 shares
    Change vs previous 13F +32,754 shares

    3.08% of the 13F portfolio, value $21,662,207.

    13F-HR 0001172661-25-004856 filed by Iron Triangle Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 105,257 shares
    Change vs previous 13F -194,743 shares

    2.8% of the 13F portfolio, value $17,683,176.

    13F-HR 0001172661-25-003343 filed by Iron Triangle Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 300,000 shares
    Change vs previous 13F +113,998 shares

    6.52% of the 13F portfolio, value $41,331,000.

    13F-HR 0001172661-25-001955 filed by Iron Triangle Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 186,002 shares
    Change vs previous 13F not available

    2.56% of the 13F portfolio, value $21,998,457.

    13F-HR 0001172661-25-000888 filed by Iron Triangle Partners LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).